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Abstract
Objectives To assess the clinical effectiveness, effect on waiting times,
and patient acceptability of PhysioDirect services in patients with
musculoskeletal problems, compared with usual care.
Design Pragmatic randomised controlled trial to assess equivalence in
clinical effectiveness. Patients were individually randomised in a 2:1
ratio to PhysioDirect or usual care.
Setting Four physiotherapy services in England.
Participants Adults (aged ≥18 years) referred by general practitioners
or self referred for musculoskeletal physiotherapy.
Interventions PhysioDirect services invited patients to telephone a
physiotherapist for initial assessment and advice, followed by face-to-face
physiotherapy if necessary. Usual care involved patients joining a waiting
list for face-to-face treatment.
Main outcome measures Numbers of appointments, waiting time for
treatment, and non-attendance rates. Primary outcome was physical
health (SF-36v2 physical component score) at six months. Secondary
outcomes included four other measures of health outcome, mental
component score and scales from the SF-36v2, time lost from work, and
patient satisfaction and preference. Participants were not blind to
allocation, but outcome data were collected blind to allocation.
Results Of 1506 patients allocated to PhysioDirect and 743 to usual
care, 85% provided primary outcome data at six months (1283 and 629
patients, respectively). PhysioDirect patients had fewer face-to-face
appointments than usual care patients (mean 1.91 v 3.11; incidence rate
ratio 0.59 (95% confidence interval 0.53 to 0.65)), a shorter waiting time
(median 7 days v 34 days; arm time ratio 0.32 (0.29 to 0.35)), and lower
rates of non-attendance (incidence rate ratio 0.55 (0.41 to 0.73)). After
six months’ follow-up, the SF-36v2 physical component score was
equivalent between groups (adjusted difference in means −0.01 (−0.80
to 0.79)). Health outcome measures suggested a trend towards slightly
greater improvement in the PhysioDirect arm at six week follow-up and
no difference at six months. There was no difference in time lost from
work. PhysioDirect patients were no more satisfied with access to
physiotherapy than usual care patients, but had slightly lower satisfaction
overall at six months (difference in satisfaction −3.8% (−7.3% to −0.3%);
P=0.031). PhysioDirect patients were more likely than usual care patients
to prefer PhysioDirect in future. No adverse events were detected.
Conclusions PhysioDirect is equally clinically effective compared with
usual care, provides faster access to physiotherapy, and seems to be
safe. However, it could be associated with slightly lower patient
satisfaction.
Trial registration Current Controlled Trials ISRCTN55666618.
Correspondence to: C Salisbury c.salisbury@bristol.ac.uk
Extra material supplied by the author (see http://www.bmj.com/content/346/bmj.f43?tab=related#webextra)
Web appendix 1: Further details of the PhysioDirect service
Web appendix 2: Reasons why referrals were ineligible for invitation
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Introduction
Healthcare systems internationally face the challenge of how
to meet increasing demand for healthcare, due to the ageing
population and rising consumer expectations within limited
resources. Healthcare providers therefore need to explore new
approaches to delivering care. One approach that has been used
in several contexts is initial assessment by telephone.1 This can
make it convenient for patients to access advice or treatment
(or both), and provides a triage function since patients who have
most to gain from early face-to-face treatment can be identified
and prioritised. Telephone based approaches have been
introduced to assess and advise patients with a wide range of
problems in primary care, although have rarely been rigorously
evaluated.1
This approach could be particularly appropriate for the
assessment and treatment of musculoskeletal problems, which
are one of the most common reasons for consulting a general
practitioner.2 Musculoskeletal problems are an important cause
of poor health because of pain and functional impairment3 and
have a major economic effect owing to time lost from work,
particularly from back pain.4 In the United Kingdom’s health
service, patients with musculoskeletal problems usually consult
in general practice initially. Many are then referred to
physiotherapy, with about 1.23 million new referrals from
general practitioners per annum in England.5 These patients are
put on a waiting list to see a physiotherapist for a face-to-face
assessment, often followed by a series of follow-up
appointments. Providing timely access to physiotherapy has
long been a problem in the NHS, with waiting times of several
weeks or months for treatment in many areas of the UK.6
For some conditions such as neck pain7 and shoulder pain,8 there
is evidence of benefit from manual therapy from a
physiotherapist. However, for other conditions such as
osteoarthritis,9 the main recommended treatment is advice about
maintaining physical activities and provision of a structured
exercise programme rather than hands on therapy. Therefore,
waiting lists might be congested with patients who could benefit
from assessment and advice from a physiotherapist, but could
have little more to gain from a course of face-to-face
appointments.
In an effort to improve access to care, several areas have
introduced PhysioDirect services, in which patients can
telephone a physiotherapist for initial assessment and advice
without waiting for a face-to-face appointment. They can be
given advice about self management and exercises over the
telephone, and the need and priority for seeing them face-to-face
can be established. Services that have implemented PhysioDirect
have claimed that it reduces waiting times for treatment, it is
popular with patients, and about half of all patients can be
managed by telephone alone.10 11 This type of service is being
introduced in several different countries, including the UK, but
there is no evidence about health outcomes or costs.12 The aim
of this study was to assess the clinical effectiveness and cost
effectiveness of PhysioDirect compared with usual models of
care based on patients joining a waiting list for physiotherapy
and eventually receiving face-to-face care. This paper describes
the findings with regard to the clinical effectiveness of
PhysioDirect, along with findings about access to care and
acceptability to patients. The economic analysis is reported
elsewhere.13
Methods
Design
We conducted a pragmatic, individually randomised controlled
trial, incorporating economic evaluation, to compare
PhysioDirect and usual care.14 The trial was designed to assess
equivalence between the two trial arms in the primary clinical
outcome. If equivalence in clinical outcome is established, the
parallel economic evaluation and secondary outcomes (such as
waiting time for treatment) become particularly important and
relevant to future provision of services. The only important
change to the study design after it had commenced was an
increase in the target number for recruitment, described below.
Setting and participants
The trial was conducted in four typical community
physiotherapy services in four different areas of England
(Bristol, Somerset, Stoke-on-Trent, and Cheshire), which drew
patients from 94 general practices covering a wide range of
types of geographical area and population. Adults (aged ≥18
years) whowere referred by general practitioners or who referred
themselves for physiotherapy for a musculoskeletal problem
were eligible for the trial. Inclusion criteria were deliberately
broad to maximise generalisability. The main exclusion criteria
were patients with non-musculoskeletal problems, referred by
hospital consultants, unable to communicate in English by
telephone, who could not be contacted, or with problems deemed
(on the basis of the referral form) to be too urgent to be delayed
by trial recruitment.
Interventions
In the UK, usual care typically involves patients with
musculoskeletal problems being referred by general practitioners
to a physiotherapist. Patients join a waiting list for the next
available face-to-face appointment, and could wait for several
weeks. After assessment, patients are usually given advice about
exercises, supported by advice leaflets. If appropriate, they are
invited to a course of further treatment sessions, which might
involve hands-on manual therapies.
Patients randomly allocated to the PhysioDirect armwere invited
to telephone a senior physiotherapist for initial assessment and
advice about treatment as soon as it was convenient.
Physiotherapists were available to receive calls during advertised
PhysioDirect sessions. The physiotherapists used computerised
templates to assess patients and record findings. As part of their
training to provide the PhysioDirect service, physiotherapists
were taught enhanced telephone communication skills, including
the use of visualisation to help assess patients’ symptoms and
functional difficulties.
At the end of the call, most patients were sent written advice
about self management and exercises and invited to telephone
back after two to four weeks to discuss progress. They were
then given further advice or offered face-to-face treatment as
necessary. The PhysioDirect assessment also made it possible
to identify patients who urgently needed face-to-face treatment
and other patients who were unlikely to gain benefit from
physiotherapy and could be discharged.
The PhysioDirect intervention was based on offering patients
an initial telephone assessment with a physiotherapist, with
face-to-face care available if necessary. Patients in the
PhysioDirect arm could decline a telephone assessment at any
time and wait for a face-to-face appointment. The comparison
was between a PhysioDirect treatment pathway that offered
early telephone advice that, by a system of triage, also allowed
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earlier face-to-face appointments if necessary, and the usual
care system in which all patients waited for a face-to-face
appointment.
The PhysioDirect services in each of the four sites were
standardised as far as possible, with physiotherapists undergoing
the same training,15 using the same assessment software, and
providing the same range of advice leaflets. These advice leaflets
were similar to those that may have been given to patients after
consultations in the usual care arm.
Computerised assessment templates and training were provided
by the physiotherapy team in Huntingdonshire, who have
provided a similar PhysioDirect service since 2001.15 This study
was completely independent, and none of the authors have any
conflict of interest in relation to the success (or otherwise) of
the intervention.Web appendix 1 provides further details of the
PhysioDirect service.
Despite the 2:1 randomisation ratio in favour of PhysioDirect,
most patients in each site continued to receive usual care,
because it included not only those randomised to usual care but
also those ineligible for the trial or declining participation. We
allocated physiotherapy staff time in each site in proportion to
the number of patients allocated to the PhysioDirect trial arm
versus all those due to receive usual care. The time available
for patients in the PhysioDirect arm included both telephone
sessions and any subsequent face-to-face consultations.
Therefore, total physiotherapy staff time per patient was similar
in both trial arms. Separate waiting lists were held for patients
in the PhysioDirect and usual care arms in each site. By these
measures, we ensured that the PhysioDirect service did not
affect the waiting time for patients in the usual care arm.
Randomisation and masking
Patients referred for physiotherapy were invited by post to
participate. Those who gave informed consent were randomised
in a 2:1 ratio to PhysioDirect or usual care using a secure remote
automated allocation system generated and hosted by the Bristol
Randomised Controlled Trials Collaboration. We used the 2:1
ratio to ensure that enough patients were randomised to
PhysioDirect to make it viable to run PhysioDirect telephone
sessions efficiently and at different times in the week.
Randomisation was conducted at the level of the patient,
stratifying by physiotherapy service and minimising by sex,
patient age group, and site of musculoskeletal problem.
Outcomes were self reported in patient questionnaires or
obtained by electronic download from the PhysioDirect software
or from physiotherapy service records. If patients did not return
questionnaires despite reminders, attempts were made to collect
primary outcome data by telephone. All outcome data were
collected by researchers who were blind to group allocation. It
was not possible for physiotherapists delivering the intervention
to be blinded.
Outcome measures
Outcomes were assessed at baseline, and at six weeks and six
months after randomisation. We collected data for the process
of care including the number, type, and duration of consultations
with physiotherapists; waiting times for treatment (defined as
first physiotherapy contact); and rates of non-attended
appointments.
The primary outcome was clinical outcome at six months,
assessed by the physical component summary measure from
the SF-36v2 questionnaire.16Weused a generic measure because
no disease specific measure was appropriate, in view of the wide
range of problems experienced by patients in this trial. Despite
concerns about the sensitivity of generic measures, the physical
component score has been shown to compare well with disease
specific measures in patients with musculoskeletal problems.17-20
To provide further reassurance that our measures were
sufficiently sensitive to detect differences between the groups
(particularly important given the equivalence nature of this trial),
we also used four other measures of clinical outcome:
• TheMeasure YourselfMedical Outcomes Profile, a tailored
and validated measure that is generated by patients. By
focusing on the main problem for which the patient was
referred to physiotherapy, this profile would be particularly
sensitive to change21
• The EQ-5D measure of health related quality of life22
• One question about overall improvement in the main
problem for which the patient was referred to physiotherapy
(global improvement score—a seven point scale from “very
much better” to “very much worse”)
• A composite measure of response to treatment including
pain, function, and overall improvement as recommended
by the Outcomes Measures in Rheumatology Clinical
Trials-Osteoarthritis Research Society International
initiative23
Other secondary outcomes included: the mental component
summary score and individual scales from the SF-36v2
questionnaire, time lost from work, patient satisfaction, and
patient preference for future care. Questions about satisfaction
with the consultation were adapted from the General Practice
Assessment Questionnaire, with additional questions about
access to the service based on preliminary interviews with
patients. We confirmed that these questions formed internally
reliable scales using rotated factor analysis. Overall satisfaction
with the service was based on one question. All questions used
six point Likert scales.
Sample size and power
The study was powered to establish clinical equivalence in the
physical component score, with a difference of no greater than
two points conservatively specified as demonstrating
equivalence.16 Sample sizes for analysis of 976 and 488 patients
in the PhysioDirect and usual care groups, respectively, would
provide 95% power to reject a null hypothesis of
non-equivalence with an overall two sided α of 0.05, assuming
that the observed difference in means was 0 and standard
deviation of the physical component score was 10.16
Assuming 20% non-collection of the primary outcomes, it was
necessary to recruit 1875 patients to reach a target of 1500
patients for analysis. Following a protocol amendment, we
continued sending invitations until 2000 patients had been
randomised, recognising that the final number recruited would
be higher because of the lag between invitation and recruitment.
This amendment was necessary because of concern about the
follow-up rate we would achieve during a national postal strike.
Statistical methods
We used descriptive statistics to compare characteristics of
patients randomised with those eligible but not randomised and
to assess the balance between the trial arms at baseline. Analyses
of primary and secondary outcomes were conducted on an
intention to treat basis without imputation—that is, all patients
were analysed according to their randomised groups, except for
those who did not provide follow-up data.We usedmultivariable
regression models to investigate between group differences,
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2013;346:f43 doi: 10.1136/bmj.f43 (Published 29 January 2013) Page 3 of 13
RESEARCH
adjusted for stratification and minimisation variables and, if
available, the value of the outcome at baseline.
Although the protocol stated that we would make adjustments
to P values arising from analyses of secondary outcomes to
account for multiple testing, we later decided not to do so, as
discussed in the limitations section of this paper.24 In sensitivity
analyses, we investigated the effect of any baseline imbalance
in outcome variables, clustering by physiotherapy service or
general practice, and missing primary outcome data, using
multiple imputation methods.25 In prespecified subgroup
analyses, we explored the effect of PhysioDirect on the primary
clinical outcome according to the site of presenting
musculoskeletal problem, patient age group, socioeconomic
status and physiotherapy service, using interaction terms in the
primary regression analysis. All statistical analyses were
conducted using Stata version 11.
Investigation of adverse events
General practitioners and physiotherapists were asked to report
any suspected adverse event that may have been related to
physiotherapy or to the trial procedures. The general practice
notes of each patient were scrutinised by researchers at the end
of the trial following a protocol designed to identify any
potential adverse events. Data about several other potential
harmswere available from themain outcomemeasures described
previously, such as continued pain or reduced function (available
from scales in the SF-36v2) and extended time off work (from
the patient questionnaire).
Trial registration
The trial was registered with Current Controlled Trials
(ISRCTN55666618) before patient recruitment, and the protocol
has been published.14
Results
Participant flow and recruitment
The figure⇓ illustrates the flow of patients during the trial. Of
4523 eligible patients, 2256 (50%) agreed to participate. Almost
all patients (98%; 2207/2256) were referred by general
practitioners, the remainder were self referred. Patients who
were randomised were slightly younger on average than those
whowere not (mean age 48 years v 52 years), but were otherwise
similar in terms of sex, deprivation, site, and referral problem.
We recruited and randomised patients between July 2009 and
December 2009; 1513 to PhysioDirect and 743 to usual care.
Seven patients were found to have been randomised to
PhysioDirect in error: two had not completed a valid consent
form and five were subsequently found to have exclusion criteria
for the trial. We excluded these patients from follow-up and
analysis. There were no important differences between groups
at baseline (table 1⇓). Primary outcome data were obtained from
88% of patients after six weeks’ follow-up and 85% of patients
after six months’ follow-up.
Process of care
Of all patients in the PhysioDirect arm, 1281 (85%) contacted
the physiotherapy service at least once. Of the 1237 patients
contacting PhysioDirect and assessed initially by telephone,
586 (47%) were managed entirely by telephone. Patients in the
PhysioDirect arm had fewer face-to-face appointments than
those in the usual care arm (mean 1.91 v 3.11; adjusted incidence
rate ratio 0.59 (95% confidence interval 0.53 to 0.65)) and fewer
physiotherapy consultations of any type (2.87 v 3.25, 0.87 (0.80
to 0.94)). Patients allocated to PhysioDirect had a shorter wait
for physiotherapy treatment than those allocated to usual care
(median 7 days v 34 days; adjusted arm time ratio 0.32 (0.29 to
0.35)). Patients in the PhysioDirect arm were also less likely to
fail to attend face-to-face appointments over six months than
those in the usual care arm (mean failure rate 0.09 v 0.12,
adjusted incidence rate ratio 0.55 (0.41 to 0.73)).
Primary and secondary outcomes
PhysioDirect and usual care were equivalent in terms of the
primary outcome of physical component score at six months’
follow-up (table 2⇓). This finding was robust to adjustment for
baseline imbalance, imputation of missing data, and adjustment
for clustering. All measures of health outcome (that is, the
primary and four secondary outcomes) showed a similar pattern.
These findings suggested a slightly greater improvement in
favour of PhysioDirect at six weeks’ follow-up, but no
differences at six months’ follow-up (tables 2 and 3⇓). However,
the differences at six weeks were small and could be clinically
unimportant.
Table 4⇓ shows no differences between study groups for the
mental component summary measure or any of the scales from
the SF-36v2 questionnaire. No evidence was found of a
difference between the two trial arms in time lost from work
(table 5⇓). Patients in the usual care arm had slightly higher
satisfaction than those in the PhysioDirect arm with regards to
the consultation and overall satisfaction. No between group
difference was evident with regards to satisfaction with access
to the service (table 6⇓).
At baseline, about a third of participants in each arm stated a
preference for usual care, stated a preference for PhysioDirect,
or expressed indifference. At six months’ follow up, 417 (42%)
of 985 patients in the PhysioDirect group and 245 (51%) of 485
patients in the usual care group preferred usual care; 393 (40%)
and 131 (27%) in each group, respectively, preferred
PhysioDirect. Multinomial logistic regression showed strong
evidence that participants in the PhysioDirect arm were more
likely than those in the usual care arm to prefer PhysioDirect
compared with being indifferent (adjusted relative risk ratio
1.98 (adjusted 95% confidence interval 1.43 to 1.98)).
No differences between trial arms in the primary outcome were
identified in relation to any of the prespecified subgroups (based
on age, referral problem, deprivation, or primary care trust site),
but potentially important differences could not be excluded
because the confidence intervals were wide (data not shown).
No adverse events were detected in either arm of the trial, which
included 4323 consultations (1445 by telephone) over sixmonths
in 1506 patients allocated to PhysioDirect.
Discussion
Compared with usual care based on waiting lists for face-to-face
appointments, a care pathway based on PhysioDirect is equally
clinically effective, provides faster access to advice and
treatment, and seems to be safe. However, there was no evidence
that this pathway was associated with improved patient
satisfaction with access to physiotherapy.
Strengths and limitations
Innovations in the delivery of healthcare are rarely accompanied
by large, multicentre, randomised controlled trials such as the
present trial, including an analysis of cost effectiveness.26 The
findings show that randomised trials of service reorganisation
are feasible and are also informative in challenging
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assumptions—for example, that faster access to care will reduce
patients’ time off work or improve satisfaction with the service.
However, our study also highlights the limitations of trials of
service innovations.27 For example, providing a new service in
the context of a trial meant providing two different care
pathways in parallel, which made it difficult to provide
PhysioDirect services throughout the week so that patients could
call when it suited them. Once the trial ended, far more patients
were treated with PhysioDirect by the services that continued
to offer it (because there was no consenting process and none
were randomised to usual care), and it was possible to provide
a more efficient and accessible PhysioDirect service than was
tested during the trial.
We observed few differences in outcomes between groups. The
differences in clinical outcomes seen after six weeks’ follow-up
might be too small to be clinically meaningful. However, the
pattern of change over time was consistent across several
different measures of clinical outcome, supporting the notion
that patients allocated to PhysioDirect had a faster improvement
in symptoms than those allocated to usual care.
The difference in patient satisfaction was also small and might
not be meaningful, with a 3.8% difference in overall satisfaction,
equating to 0.19 points on a six point scale ranging from “very
poor” to “excellent.” The fact that patients in the PhysioDirect
arm (of whom almost half (47%) were managed entirely by
telephone) were almost as satisfied with their consultations as
patients in the usual care arm (of whom almost all had
face-to-face consultations only) might provide reassurance that
physiotherapists are able to provide assessments and advice by
telephone in a way that is reasonably acceptable to patients.
The findings about patient satisfaction were also limited because
these questions were only answered by people who had had
contact with a physiotherapist. By six weeks’ follow-up, 50%
of the patients in the usual care arm (compared with 19% of
those in the PhysioDirect arm) had not had any contact. These
patients did not complete the questionnaire but may have been
those most likely to express dissatisfaction with access.
We did not make adjustments to P values arising from analyses
of secondary outcomes to account for multiple testing, which
is at variance from the protocol. Our focus was on the magnitude
of between arm differences in outcomes using confidence
intervals, rather than hypothesis testing using P values, as a
basis for interpretation and decision making. The subject of
adjustment for multiple testing has been debated at length by
statisticians,24 and on reflection we decided that the adjustment
as stated in the protocol was unnecessary in this case.
The pragmatic nature of this study, which includes a wide range
of patients and several physiotherapy sites, makes the findings
potentially generalisable to physiotherapy services in the NHS,
as well as to the many other countries in which patients
experience long delays in accessing physiotherapy.28 However,
only 50% of eligible patients agreed to participate. Although
this rate of recruitment was high for a community based trial,
and no important differences were observed between participants
and non-participants, the rate still raises questions about external
validity. We do not have data about whether people declined
because they did not wish to take part in research or did not
want to receive PhysioDirect. However, our recruitment rate
suggests that at least 50% would consider using PhysioDirect
if it were offered.
Implications
This study provides justification for PhysioDirect as a safe and
effective way of reducing delays for advice about
musculoskeletal problems for patients referred by general
practitioners for physiotherapy. But, in view of the slight
reduction in patient satisfaction, our results do not provide a
compelling argument in favour of PhysioDirect. However, our
associated economic analysis (reported elsewhere)13 suggests
that the slightly earlier advice and treatment provided by
PhysioDirect means that the service is likely to be more cost
effective than usual pathways of care from a health service
perspective, which will be of interest to commissioners.
In future, PhysioDirect services will probably be provided more
often in conjunction with direct access for patients to
physiotherapists (rather than after referral from another
healthcare professional), and PhysioDirect could be offered as
a choice for patients wanting quicker advice rather than as the
only route to care.29 Patients who self refer will probably have
less serious problems of shorter duration than those referred by
general practitioners,29 and in these circumstances, the benefits
of initial telephone assessment and advice via PhysioDirect
could be greater.
The PhysioDirect services in this study used experienced
physiotherapists to provide telephone assessments supported
by computerised assessment templates. Some PhysioDirect
services that have been recently established use less experienced
physiotherapists who are not supported by computerised
templates. It should not be assumed that our findings are
applicable under these circumstances.
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What is already known on this topic
Under the PhysioDirect care pathway, patients are invited to telephone a physiotherapist for initial assessment and advice, followed by
face-to-face physiotherapy if necessary
Several observational studies have suggested benefits of PhysioDirect services for patients with musculoskeletal problems, in relation
to improved process of care and patient satisfaction
Research on similar systems of telephone assessment and advice in other clinical settings has shown that they can be safe, clinically
accurate, cost effective, and acceptable to patients, and can reduce clinicians’ workload
What this study adds
Half of the patients referred by general practitioners to physiotherapy could be managed by telephone, reducing delays for initial treatment
advice and non-attendance rates at subsequent face-to-face appointments
PhysioDirect was as clinically effective as usual care (based on joining waiting lists for appointments without telephone consultation),
and seemed to be safe
Reduced delays for physiotherapy were not associated with increased patient satisfaction with access to care, and overall satisfaction
of patients was slightly lower for PhysioDirect than for usual care
Data sharing: Participants did not give informed consent for data sharing
but the data are anonymised and the risk of identification is low. Data
from the trial may be available from the corresponding author at
c.salisbury@bristol.ac.uk subject to agreement about the use of the
data.
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Tables
Table 1| Baseline characteristics of randomised patients*
No (%) of patients
PhysioDirect (n=1506, 67%)Usual care (n=743, 33%)
897 (60)438 (59)Female sex†
48(37-61)48(36-62)Age (years)†‡
1,439 (97)705 (96)White ethnicity
925 (62)417 (57)Employed
Site of musculoskeletal problem†
185 (12)89 (12)Cervical
35 (2)13 (2)Thoracic
412 (27)203 (27)Lumbar
351 (23)174 (23)Upper limb
450 (30)225 (30)Lower limb
8 (1)7 (1)Widespread pain
55 (4)27 (4)Multiple
10 (1)4 (1)Other
Primary care trust†
499 (33)251 (34)Bristol
348 (23)165 (22)Somerset
353 (23)174 (23)Cheshire
306 (20)153 (21)Stoke
0 (0-5)0 (0-5)Time off work (days)‡
36.81 (8.88)37.72 (8.63)SF-36v2 (physical component score)§
*Excluding seven patients excluded after randomisation.
†Stratification/minimisation variable.
‡Median (interquartile range).
§Mean (standard deviation).
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Table 2| Between group differences in SF-36v2 physical component score
PDifference (95% CI)*
Mean (standard deviation) score, sample size
Time after randomisation PhysioDirectUsual care
0.240.42 (−0.28 to 1.12)41.57(10.26), 133241.81 (10.30), 6536 weeks
0.99−0.01 (−0.80 to 0.79)43.50 (10.94), 128344.18 (10.84), 6296 months†
*Adjusted for outcome at baseline, sex, age, referral problem, and primary care trust.
†Defined as the primary follow-up point.
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Table 3| Between group differences in secondary health related outcomes
Regression analysis*Mean (SD) score, sample size
PDifference (95% CI)PhysioDirectUsual care
Measure Yourself Medical Outcomes Profile†
——3.84 (0.99), 15043.80 (0.99), 743Baseline
0.001−0.19 (−0.30 to −0.07)2.76 (1.28), 11012.92 (1.21), 5616 weeks
0.73−0.02 (−0.16 to 0.11)2.40 (1.43), 10332.40 (1.38), 5186 months
EQ-5D‡
——0.53 (0.30), 14800.56 (0.29), 731Baseline
0.290.01 (−0.01 to 0.03)0.64 (0.27), 10800.64 (0.26), 5546 weeks
0.610.01 (−0.02 to 0.03)0.69 (0.27), 10200.69 (0.27), 5086 months
Global improvement score‡
NANANANABaseline
0.020.15 (0.02 to 0.28)3.69 (1.28), 10893.54 (1.19), 5526 weeks
0.32−0.08 (−0.23 to 0.08)4.01 (1.44), 10014.07 (1.40), 5016 months
Response to treatment using OMERACT-OARSI criteria23‡§
NANANANA
0.011.37 (1.08 to 1.75)306 (28.2)/1085124 (22.6)/5506 weeks
0.241.14 (0.92 to 1.43)430 (41.8)/1029197 (38.6)/5106 months
NA=not applicable; OMERACT=Outcome Measures in Rheumatology; OARSI=Osteroarthritis Research Society International; SD=standard deviation.
*Adjusting for baseline outcome, age, sex, referral problem, and primary care trust.
†Lower value indicates better outcome.
‡Higher value indicates better outcome.
§Data are no (%) of participants who responded/total sample size, and odds ratio (95% confidence interval).
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Table 4| Mental component scores and individual scales from the SF-36v2 questionnaire by trial arm and follow-up period
Regression analysis* (arm
difference (95% CI), P)
Mean (standard deviation) score, sample size
Outcome 6 months6 weeks
6 months6 weeksBaseline
PDUCPDUCPDUC
0.11 (−0.83 to
1.05), 0.82
−0.03 (−0.88 to
0.82), 0.94
49 (11.9),
1283
48.7 (11.8),
629
48.7 (12),
1332
48.7 (12.2),
653
46.1 (12.6),
1504
45.7 (13.3),
743
Mental
component
score
0.00 (−0.75 to
0.75), 1.00
0.52 (−0.19 to
1.23), 0.14
44.7 (11.2),
1284
45.2 (10.8),
632
43.0 (10.9),
1338
43.0 (10.8),
656
39.3 (10.4),
1506
39.9 (10.2),
743
Physical
functioning
−0.08 (−1.00 to
0.84), 0.86
0.27 (−0.60 to
1.15), 0.52
45.0 (11.5),
1284
45.5 (11.5),
630
43.0 (11.3),
1336
43.2 (11.6),
655
36.7 (10.9),
1502
37.4 (11.2),
743
Role-physical
0.04 (−0.81 to
0.90), 0.93
0.06 (−0.68 to
0.80), 0.89
43.1 (10.6),
1284
43.2 (10.5),
632
40.9 (9.9),
1338
41.1 (9.6),
657
34.6 (8.2),
1506
34.9 (8.2),
743
Bodily pain
−0.14 (−0.79 to
0.51), 0.66
−0.07 (−0.66 to
0.51), 0.81
45.7 (11.1),
1284
46.1 (10.6),
634
45.3 (10.8),
1338
45.9 (10.5),
657
44.6 (10.7),
1506
45.1 (10.5),
743
General health
−0.23 (−1.05 to
0.60), 0.59
0.35 (−0.40 to
1.11), 0.35
47.0 (11.1),
1283
47.4 (10.5),
632
46.3 (10.8),
1334
46.3 (10.8),
655
43.4 (10.7),
1506
43.7 (10.6),
743
Vitality
0.34 (−0.61 to
1.30), 0.48
0.25 (−0.69 to
1.18), 0.58
46.2 (12.2),
1284
46.1 (12.0),
632
45.0 (12.4),
1338
45.1 (12.2),
657
39.8 (12.6),
1504
40.4 (12.8),
743
Social
functioning
−0.06 (−1.07 to
0.95), 0.92
−0.32 (−1.24 to
0.59), 0.51
47.1 (12.4),
1283
47.1 (12.2),
630
46.2 (12.9),
1334
46.6 (12.7),
655
42.3 (14.3),
1498
42.1 (14.6),
743
Role-emotional
0.18 (−0.67 to
1.04), 0.72
0.24 (−0.55 to
1.02), 0.57
48.7 (11.3),
1283
48.3 (11.44),
632
48.2 (11.2),
1334
47.9 (11.4),
655
45.8 (11.4),
1506
45.4 (11.7),
743
Mental health
UC=usual care; PD=PhysioDirect.
*Adjusting for baseline outcome, age, sex, referral problem, and primary care trust.
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Table 5| Between group differences in time lost from work.* Data are mean (standard deviation), median (interquartile range), and sample
size, unless stated otherwise
PArm time ratio (95% CI)†PhysioDirectUsual careReason for time lost from work
Condition for which referred (days)
NANA3.00 (7.53), 0 (0-2), 8663.10 (7.72), 0 (0-2), 395Baseline
0.27−0.95 (−3.02 to 1.05)4.39 (11.44), 0 (0-2), 5115.35 (15.22), 0 (0-2), 2536 weeks
0.940.08 (−3.21 to 3.35)7.01 (18.03), 0 (0-3), 3907.14 (22.24), 0 (0-2), 2006 months
Physiotherapy (h)
NANANANABaseline
0.94−0.01 (−0.14 to 0.18)0.40 (2.35), 0 (0-0), 13400.40 (1.21), 0 (0-0), 6566 weeks
0.85−0.04 (−0.37 to 0.33)0.95 (4.73), 0 (0-0), 12110.98 (2.80), 0 (0 to 0), 5986 months
NA=not applicable.
*Analysis only included patients who were in work.
†Adjusting for baseline outcome, age, sex, referral problem, and primary care trust.
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Table 6| Between group differences in patient satisfaction at six week and six month follow-up
Regression analysis†Satisfaction (% of maximum score* (mean (SD)), sample size)
PArm difference (95% CI)PhysioDirectUsual care
Satisfaction with physiotherapy consultation
<0.001−4.9 (−7.1 to −2.7)77.6 (18.7), 89082.5 (17.6), 3786 weeks
0.005−3.4 (−5.9 to 0.97)75.7 (20.1), 75079.2 (19.2), 3686 months
Satisfaction with access to physiotherapy
0.502−0.8 (−3.4 to 1.7)70.6 (22.3), 86971.4 (21.1), 3816 weeks
0.9600.1 (−2.7 to 2.8)69.2 (22.0), 74069.1 (20.8), 3676 months
Overall satisfaction with service
<0.001−6.5 (−9.6 to −3.4)77.3 (27.4), 88583.7 (25.2), 3836 weeks
0.031−3.8 (−7.3 to −0.3)75.9 (28.3), 73979.7 (26.5), 3676 months
*Higher scores indicate greater satisfaction.
†Adjusting for baseline outcome, age, sex, referral problem, and primary care trust.
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Figure
CONSORT diagram: flow of participants through the trial. No English means that patients did not understand English.
*Percentages expressed as n/1506×100%. †Percentages expressed as n/743×100%
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